Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

FHS
June 29, 2023
5:20 am

Albumedix Ltd., an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.

Biden’s Supreme Court abortion wins could be short-lived

WASHINGTON — The Supreme Court this month handed President Biden a pair of wins on abortion rights — but they could be short-lived. The court

June 27, 2024

STAT Virtual Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us

December 1, 2023

Trinity College Dublin researchers uncover key to enhancing MRSA vaccine efficacy

Researchers from Trinity College Dublin have taken a leap forward in understanding how we might fight back against the potentially deadly MRSA bacterium.

July 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.